Bacterial toxin sets the course for infection
cterial toxin sets the course for infection
Whether an immune cell divides, alarms other immune cells or dies is strictly controlled in our immune system. "Molecular switches? influence these processes and basically set the course for different pathways. In light of the evolutionary competition between the immune system and the microbes, researchers have found that bacteria produce different substances to manipulate the position of the switches to their advantage.
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Hannover Medical School (MHH) have examined one of those substances in more detail. Their results have been published in the American scientific magazine PLOS Pathogens. The team led by Prof Petra Dersch, head of the Department "Molecular Infection Biology?, became aware of the molecule called CNFy, because the bacterium Yersinia pseudotuberculosis produces it in large quantities.
Yersinia pseudotuberculosis is transmitted via contaminated food and can generate gastro-intestinal diseases. However, not all strains produce CNFy. The scientists had therefore assumed that it played no significant role. The interdisciplinary team has now shown that this was a mistake. "Bacteria only produce molecules that are useful for their purposes. Therefore, we wanted to know why Yersinia would need CNFy,? Dersch says.
In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFy in such a way that it lost the ability to produce this factor. "The altered bacterium was no longer capable of escaping the immune system of the host organism and could not cause disease,? reports Janina Schweer, PhD student at the HZI. This is remarkable since the bacteria certainly have other pathogenic characteristics in their repertoire. They have large molecular complexes at their disposal with which they can inject destructive substances into the host cell. This is a very effective method to promote an infection. "It seems that this mechanism is not sufficiently active in some Yersinia. Apparently, the examined Yersinia strain needs CNFy so that its "molecular syringes? can inject sufficient quantities of active substances into the immune cells,? explains Prof Jochen Hühn, head of the Department "Experimental Immunology? at the HZI. These active substances, mostly cell toxins, damage the immune cells. Many of the substances cause cell mortality. This facilitates the expansion of Yersinia within the infected organism. During advanced infections, inflammation occurs, as well as damage to the tissue.
The researchers have also identified the molecular target that CNFy manipulates, generating the dramatic consequences: this involves the so-called small Rho GTPases. These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.
"We here have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFy, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively,? explains Dersch. "It sets the course for an efficient infection and triggers onset of the disease.?
The present study shows that CNFy is very important for Yersinia. At the same time, it emphasizes the central role of the injection apparatus that is deployed in a more robust manner via CNFy - it is, and remains, an important drug target for intervention measures.
Original publication:
Janina Schweer, Devesha Kulkarni, Annika Kochut, Jörn Pezoldt, Fabio Pisano, Marina C. Pils, Harald Genth, Jochen Hühn und Petra Dersch
The cytotoxic necrotizing factor of Yersinia pseudotuberculosis (CNFy) enhances inflammation and Yop delivery during infection by activation of Rho GTPases.
PLOS Pathogens, 2013
Gastrointestinal infections trigger a wide range of intestinal disorders. They are caused by bacteria such as Yersinia. The Department "Molecular Infection Biology? studies how Yersinia attaches to the intestinal cell layer, prevents attacks of the immune system and spreads within the body.
The Department "Experimental Immunology" at the HZI studies the development of immune cells and the cellular and molecular mechanisms that keep the immune system in balance. The scientists pay particular attention to the so-called regulatory T cells.
The Helmholtz Centre for Infection Research (HZI)
Scientists at the Helmholtz Centre for Infection Research in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body?s response to infection. Helping to improve the scientific community?s understanding of a given bacterium?s or virus? pathogenicity is key to developing effective new treatments and vaccines.
www.helmholtz-hzi.de
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Inhoffenstraße 7
38124 Braunschweig
Telefon: +49 (0)531 6181-0
Telefax: +49 (0)531 6181-2655
URL: http://www.helmholtz-hzi.de/
(pressrelations) - ets the course for infection
Whether an immune cell divides, alarms other immune cells or dies is strictly controlled in our immune system. "Molecular switches? influence these processes and basically set the course for different pathways. In light of the evolutionary competition between the immune system and the microbes, researchers have found that bacteria produce different substances to manipulate the position of the switches to their advantage.
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Hannover Medical School (MHH) have examined one of those substances in more detail. Their results have been published in the American scientific magazine PLOS Pathogens. The team led by Prof Petra Dersch, head of the Department "Molecular Infection Biology?, became aware of the molecule called CNFy, because the bacterium Yersinia pseudotuberculosis produces it in large quantities.
Yersinia pseudotuberculosis is transmitted via contaminated food and can generate gastro-intestinal diseases. However, not all strains produce CNFy. The scientists had therefore assumed that it played no significant role. The interdisciplinary team has now shown that this was a mistake. "Bacteria only produce molecules that are useful for their purposes. Therefore, we wanted to know why Yersinia would need CNFy,? Dersch says.
In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFy in such a way that it lost the ability to produce this factor. "The altered bacterium was no longer capable of escaping the immune system of the host organism and could not cause disease,? reports Janina Schweer, PhD student at the HZI. This is remarkable since the bacteria certainly have other pathogenic characteristics in their repertoire. They have large molecular complexes at their disposal with which they can inject destructive substances into the host cell. This is a very effective method to promote an infection. "It seems that this mechanism is not sufficiently active in some Yersinia. Apparently, the examined Yersinia strain needs CNFy so that its "molecular syringes? can inject sufficient quantities of active substances into the immune cells,? explains Prof Jochen Hühn, head of the Department "Experimental Immunology? at the HZI. These active substances, mostly cell toxins, damage the immune cells. Many of the substances cause cell mortality. This facilitates the expansion of Yersinia within the infected organism. During advanced infections, inflammation occurs, as well as damage to the tissue.
The researchers have also identified the molecular target that CNFy manipulates, generating the dramatic consequences: this involves the so-called small Rho GTPases. These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.
"We here have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFy, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively,? explains Dersch. "It sets the course for an efficient infection and triggers onset of the disease.?
The present study shows that CNFy is very important for Yersinia. At the same time, it emphasizes the central role of the injection apparatus that is deployed in a more robust manner via CNFy - it is, and remains, an important drug target for intervention measures.
Original publication:
Janina Schweer, Devesha Kulkarni, Annika Kochut, Jörn Pezoldt, Fabio Pisano, Marina C. Pils, Harald Genth, Jochen Hühn und Petra Dersch
The cytotoxic necrotizing factor of Yersinia pseudotuberculosis (CNFy) enhances inflammation and Yop delivery during infection by activation of Rho GTPases.
PLOS Pathogens, 2013
Gastrointestinal infections trigger a wide range of intestinal disorders. They are caused by bacteria such as Yersinia. The Department "Molecular Infection Biology? studies how Yersinia attaches to the intestinal cell layer, prevents attacks of the immune system and spreads within the body.
The Department "Experimental Immunology" at the HZI studies the development of immune cells and the cellular and molecular mechanisms that keep the immune system in balance. The scientists pay particular attention to the so-called regulatory T cells.
The Helmholtz Centre for Infection Research (HZI)
Scientists at the Helmholtz Centre for Infection Research in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body?s response to infection. Helping to improve the scientific community?s understanding of a given bacterium?s or virus? pathogenicity is key to developing effective new treatments and vaccines.
www.helmholtz-hzi.de
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Inhoffenstraße 7
38124 Braunschweig
Telefon: +49 (0)531 6181-0
Telefax: +49 (0)531 6181-2655
URL: http://www.helmholtz-hzi.de/
Themen in diesem Fachartikel:
Unternehmensinformation / Kurzprofil:
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Inhoffenstraße 7
38124 Braunschweig
Telefon: +49 (0)531 6181-0
Telefax: +49 (0)531 6181-2655
URL: http://www.helmholtz-hzi.de/
Datum: 08.11.2013 - 09:01 Uhr
Sprache: Deutsch
News-ID 976976
Anzahl Zeichen: 0
pressrelations.de – ihr Partner für die Veröffentlichung von Pressemitteilungen und Presseterminen, Medienbeobachtung und Medienresonanzanalysen
Dieser Fachartikel wurde bisher 156 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Bacterial toxin sets the course for infection"
steht unter der journalistisch-redaktionellen Verantwortung von
Helmholtz-Zentrum für Infektionsforschung (HZI) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).